Marker Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
MRKR on Nasdaq
Industry
Pharmaceutical Preparations
Location
2450 Holcombe Blvd, Suite Bcm A, Ms: Bcm251, Houston, TX

Insiders trading volume in the past year

Marker Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
New Enterprise Associates 16, L.P. 10%+ Owner $5.2M +$1.77M +51.7% Dec 23, 2024
Steve Elms Director $1.05M +$35.5K +3.49% Nov 17, 2025
Peter L. Hoang President and CEO, Director $234K Mar 24, 2022
Anthony H. Kim Chief Financial Officer $55.5K Mar 24, 2022
Frederick G. Wasserman Director $31.6K Jun 8, 2021
David Laskow-Pooley Director $26.8K May 24, 2022
Kathryn Penkus Corzo Director Oct 31, 2025
Katharine Knobil Director Nov 17, 2025
Eliot M. Lurier Interim CFO Jun 30, 2023
Gerald Garrett Vice President, Clinical Ops. Feb 17, 2022
Norman David Eansor Director Nov 17, 2025
John Robert Wilson Director Jun 6, 2023
Juan Vera Chief Executive Officer, Director Oct 31, 2025
Michael Loiacono Chief Accounting Officer Feb 27, 2023
Anna Szymanska Vice President, Quality Feb 27, 2023
Nadia Agopyan SVP, Regulatory Affairs Feb 27, 2023
Tsvetelina P. Hoang VP, Research and Development Feb 27, 2023
Mythili Koneru Chief Medical Officer Feb 27, 2023

Recent Insider Transactions by Companies or Individuals for Marker Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.